The research-based startup, Cerenion Oy, got a half million euros seed investment from Butterfly Ventures and Icebreaker.vc. It develops C-TrendTM brain monitoring technology for use in intensive care. Technology is based on standard EEG-measurement, advanced machine learning algorithms and artificial intelligence.
The technology was developed at the University of Oulu (research unit of Computer Science and Engineering) and underwent clinical studies at the Oulu University Hospital as part of a two-year Tekes-funded TUTLI-project. The TUTLI funding is aimed to create new research-based business.
Cerenion was founded in May 2017 by the key personnel of the TUTLI-project, all of whom are now employed by the company.
The new funding will enable Cerenion to expand its clinical study program, seek regulatory certification for its technology and bring it to market in collaboration with strategic partner companies.
Picture: Cerenion Oy
Last updated: 24.10.2018